chrisvoncsefalvay/vaers-outcomes huggingface dataset:
didn't feel good for a couple of days; lymph nodes on her clavicle swelled up like "jellybeans; left arm hurt; >35 days between 1st and 2nd dose; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (didn't feel good for a couple of days), LYMPHADENOPATHY (lymph nodes on her clavicle swelled up like "jellybeans), VACCINATION SITE PAIN (left arm hurt) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days between 1st and 2nd dose) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048C21A and 005C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Lasted for one month) on 20-Nov-2020 and Surgery (Vein Surgery). Concurrent medical conditions included Allergy (glue that is used after Surgery to close wounds.) and Blood pressure low.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jun-2021, the patient experienced MALAISE (didn't feel good for a couple of days), LYMPHADENOPATHY (lymph nodes on her clavicle swelled up like "jellybeans), VACCINATION SITE PAIN (left arm hurt) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days between 1st and 2nd dose). On 23-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (>35 days between 1st and 2nd dose) had resolved. At the time of the report, MALAISE (didn't feel good for a couple of days) had resolved and LYMPHADENOPATHY (lymph nodes on her clavicle swelled up like "jellybeans) and VACCINATION SITE PAIN (left arm hurt) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter No treatment medications provided by the reporter.   This case was linked to MOD-2022-454960, MOD-2022-455051 (Patient Link).
headache; sore arm; sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of the first episode of VACCINATION SITE PAIN (sore arm), HEADACHE (headache) and the second episode of VACCINATION SITE PAIN (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced the first episode of VACCINATION SITE PAIN (sore arm). On 26-Feb-2021, the patient experienced HEADACHE (headache) and the second episode of VACCINATION SITE PAIN (sore arm). At the time of the report, HEADACHE (headache) and the last episode of VACCINATION SITE PAIN (sore arm) outcome was unknown.            No concomitant medication were reported No treatment medication were reported. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable
Uncontrollable chills, fever, nausea. Dizziness, weak, shaking, loss of appetite.  Duration of symptoms from 5am 11/28 to 9am 11/29.  Slept under the blankets for duration of symptoms. Did not go to the doctor.
Hands hurt/arm was sore; Feet hurt; Legs hurt; Fever of 99.1; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hands hurt/arm was sore), PAIN IN EXTREMITY (Feet hurt), PAIN IN EXTREMITY (Legs hurt), PYREXIA (Fever of 99.1) and HEADACHE (Headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A, 011L20A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced PAIN IN EXTREMITY (Hands hurt/arm was sore), PAIN IN EXTREMITY (Feet hurt), PAIN IN EXTREMITY (Legs hurt), PYREXIA (Fever of 99.1) and HEADACHE (Headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse reaction, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Hands hurt/arm was sore), PAIN IN EXTREMITY (Feet hurt), PAIN IN EXTREMITY (Legs hurt), PYREXIA (Fever of 99.1) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Nov-2021, Body temperature: high (High) fever of 99.1.         No Concomitant product use was reported.  The patient after receiving the booster dose of the vaccine started to have a headache and their hands, feet and legs were hurting. The patient's arm was sore, and they had a fever of 99.1. The patient was scheduled to get a CT with PO and IV contrast soon.  The patient stated that it all started at 04-Nov-2021 morning at 1:00 AM and they took an Advil for their symptoms. Reportedly, the patient had not discussed this with their HCP.
This spontaneous report was received from a pharmacist referring to a 69 years old female patient with hypertension. The patient had no drug reactions/allergies. On 12-MAY-2016 the patient was vaccinated with ZOSTAVAX (Lot# reported as L044528, expiration date 09-FEB-2017) subcutaneously. Concomitant therapies included propranolol hydrochloride (manufacturer unknown) and amlodipine. The pharmacist reported that on 12-MAY-2016 the patient experienced dizziness which persisted several hours following vaccination, a low heart rate of 50 Bpm (beats per minutes) and slight redness that localized at the injection site immediately following the administration of ZOSTAVAX. The patient sought unspecified medical attention. It was unknown if treatment was given for adverse events. Other laboratory tests were not performed. The patient was still dizzy at the time of reporting. The outcomes of heart rate decreased and injection site erythema were unknown. Reporter's causality was not provided. Additional information has been requested.
sick; patient could not breath in through his nose for months; Initial and follow up information received on 07-Nov-2020 and 09-Nov-2020 regarding an unsolicited valid non-serious social media  case received from a consumer (patient).This case was linked to case 2020SA314884 (same reporter).  This case involves a male patient (age not reported) who was sick (illness) and could not breath in through his nose for months (Mouth breathing), while he received INFLUENZA VACCINE.  The patient's past medical treatment(s), vaccination(s), concomitant medications and family history were not provided. At the time of the event, the patient was allergic to several medications, penicillin, amoxicillin and did not know what else might react on him.  On an unknown date (reported as 30 years ago), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number and expiry date not reported via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick (illness) and could not breath in through his nose for months (Mouth breathing) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported that he had to live on nasal spray to breath. Had no flu shot ever again. His doctor tried every year to get him to take a flu shot, but like he said never again he would rather take any chances.  Other relevant tests not reported.  At the time of reporting, outcome for events was unknown.  There will be no information on the batch number for this case.
Heart palpitations; Irregular heart beat; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Aug2021 at 11:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included lots of environmental allergies and eosinophilic esophagitis. The patient was allergic to sulfa drug, peanut (possibly) and wheat. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included escitalopram oxalate (LEXAPRO), cetirizine hydrochloride (ZYRTEC), fluticasone propionate (FLONASE) and omeprazole (MANUFACTURER UNKNOWN); all taken for an unknown indication on an unknown date and unknown if ongoing. On 31Aug2021 at 16:00, on day 3 after vaccination, the patient experienced heart palpitations and irregular heartbeat which was going on since 12 hours (at the time of reporting). The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with aspirin and magnesium. The clinical outcome of the events heart palpitations and irregular heartbeat was not resolved at this time of this report.
ITCHINESS ALL OVER BODY AND FOREHEAD; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced itchiness all over body and forehead. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itchiness all over body and forehead. This report was non-serious.
having a real kind of tinny taste in mouth, funky metal taste in mouth; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Apr2021 (Lot number: EW0162) at the age of 73 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSGEUSIA (non-serious) with onset 16Apr2021, outcome "recovering", described as "having a real kind of tinny taste in mouth, funky metal taste in mouth".  Additional information included: Caller reported it was about the same, maybe a little less than what it was when the caller first noticed. Kind of like that taste you got in mouth when a person has an MRI and they put that contrast in there, kind of like a funny taste. The patient had no emergency room or Physician office. No prior vaccinations within 4 weeks. No AE(s) following prior vaccinations. No patient's Medical History (including any illness at time of vaccination) and no family medical history.   No follow-up attempts are possible. No further information is expected.
W/in 48 hours I had 4 oozing, itchy bumps on scalp - 3 have mostly cleared up but one (attempted photo att'd) remains 4 days later. Also, I now have what I think is pink eye.
Symptoms: Started with a rash in the left axillary region. Itching spread across all of upper torso. Itchy rash with hives. Diagnosed as unknown urticaria. Prednisone 20mg 1 time per day and hydroxyzine 10mg 3-4 times a day. After 1 days, symptoms have improved but not resolved
VACCINE ADMINISTERED AFTER THE 31 DAY REFRIDGERTATED BEYOND USE DATE BUT BEFORE THE 45 DAY EXCURSION DATE.
COVID-19 case I started out coughing and developed a fever with green discharge coming from my lungs. Severe fatigue and joint aches. And headache. Symptoms lasted for about 10days and I still have a clogged up nose and this is the 14th day. I was given Remdesivir.
1" bumps (on right wrist, right inner forearm and on left shoulder a few inches away from the; nausea; Fever/low grade fever; itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the; chills; aches; headaches; redness (on right wrist, right inner forearm and on left shoulder a few inches away from the; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), PYREXIA (Fever/low grade fever), PRURITUS (itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the), CHILLS (chills) and PAIN (aches) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced NAUSEA (nausea), PYREXIA (Fever/low grade fever), PRURITUS (itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the), CHILLS (chills), PAIN (aches), HEADACHE (headaches) and ERYTHEMA (redness (on right wrist, right inner forearm and on left shoulder a few inches away from the). On 10-Feb-2021, the patient experienced SWELLING (1" bumps (on right wrist, right inner forearm and on left shoulder a few inches away from the). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 10-Feb-2021, NAUSEA (nausea), CHILLS (chills) and PAIN (aches) had resolved, PYREXIA (Fever/low grade fever) outcome was unknown. At the time of the report, PRURITUS (itchiness (on right wrist, right inner forearm and on left shoulder a few inches away from the), HEADACHE (headaches), ERYTHEMA (redness (on right wrist, right inner forearm and on left shoulder a few inches away from the) and SWELLING (1" bumps (on right wrist, right inner forearm and on left shoulder a few inches away from the) had not resolved.            No concomitant medications reported by investigator
Pt recv vax on 11/4/98; 2 hr post vax pt exp red/ glassy eyes & no  energy
Dose 3; body aches; body joint aches; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient in her 50's received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, 2 previous Pfizer Covid-19 , vaccinations with minimal aches or joint pain.), for COVID-19 immunization, reaction(s): "minimal aches or joint pain", "minimal aches or joint pain"; Bnt162b2 (2nd dose, 2 previous Pfizer Covid-19 , vaccinations with minimal aches or joint pain.), for COVID-19 immunization, reaction(s): "minimal aches or joint pain"; Bnt162b2 (2nd dose, 2 previous Pfizer Covid-19 , vaccinations with minimal aches or joint pain., No underlying conditions known), for COVID-19 immunization, reaction(s): "minimal aches or joint pain". The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Dose 3"; PAIN (non-serious), outcome "unknown", described as "body aches"; ARTHRALGIA (non-serious), outcome "unknown", described as "body joint aches". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a other health professional via call center representative and described the occurrence of injection site erythema in a 53-year-old female patient who received SHINGRIX (batch number Z9RR4, expiry date 15th November 2020) for prophylaxis. On an unknown date, the patient received SHINGRIX (subcutaneous) .5 ml. On an unknown date, unknown after receiving SHINGRIX, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown. Additional information was received as follows: This case was reported by pharmacy intern. The health care professional stated that the patient inadvertently received the dose of SHINGRIX subcutaneously instead of the indicated intramuscular route, which led to the intramuscular formulation administered by other route. Additional information was received as follows: This case was reported by pharmacy intern. The health care professional stated that the patient inadvertently received the dose of SHINGRIX subcutaneously instead of the indicated intramuscular route, which led to the intramuscular formulation administered by other route. Follow up information was received from other healthcare professional on 3rd October 2018: The patient's demographic details were updated. On 3rd July 2018, the patient received the 1st dose of SHINGRIX. In July 2018, less than a month after vaccination, the injection site was red for several days, but no other adverse events were occurred. SHINGRIX was processed through insurance, covered and the patient received the vaccine subcutaneously unintentionally instead of intramuscularly. The patient was immediately informed once the medication error was discovered. The VAERS details were updated. This case was associated with medication error with adverse event. It was unknown if the reporter considered the injection site erythema to be related to SHINGRIX.
Breakthrough case admission after 2 vaccines Moderna 2/12/21 Lot# 015M20A;  Moderna 3/11/21 Lot# 044A21A
The patient is a 65-year-old male with a past medical Hx BPH- hypertension, diabetes mellitus, coronary artery disease PCI stent, chronic kidney disease.  The patient presented on 7/27/21 with complaints of cough, nausea, vomiting, body aches, subjective fever, chills and worsening shortness of breath for the past 2 weeks.  He states that he received a Johnson & Johnson vaccine x1 dose.  He lives with his wife who also received the same vaccine x1 dose. She is not sick. He believes that he may have had contact with Covid 19 at the center.  He has not been able to keep medications down nor food.  His symptoms have worsened in the past few days, and he came into the ER for further evaluation.  Initial workup in the ER, temp 100.2°, heart rate 94, respirations 18, blood pressure 144/79.  O2 sat 93% now on O2 2 L nasal cannula.  Labs-white count 10.92, hemoglobin 11.4, hematocrit 34.1, platelets 263, sodium 131, potassium 5.1, BUN 49, creatinine 3.10, glucose 135.  Chest x-ray-subtle patchy bilateral infiltrates. He was diagnosed with COVID pneumonia on 7/27/21. He received remdesivir and dexamethasone and continues to be on 4L NC on 8/6/21.
After the shot I developed a bright red circle at injection site in my right arm.  It lasted about two week with red spot and soar arm.  The shot was given 9-16-23 and I am still experiencing pain in my right arm that I never had before the injection, and weakness.  When I lift my arm it hurts near injection site like a needle is in my arm and muscle weakness.  It hurts to lift items with that arm now.  This arm has never had this kind of pain.
Information has been received from a health professional concerning a 27 year old female who on 02-AUG-2007 was vaccinated with her first dose of GARDASIL vaccine (yeast) (lot# 658084/0524U). On 27-SEP-2007 the patient was vaccinated with her second dose of GARDASIL vaccine (yeast) (lot# 658563/1063U). On 29-SEP-2007 the patient was breaking out in hives all over her body, feeling sun burned and experienced an upset stomach. The patient sought medical attention by calling the doctor's office and was instructed to take diphenhydramine hydrochloride (Benadryl). Subsequently, the patient recovered from hives, feeling sun burned and upset stomach. The patient did not experience any adverse events after Dose 1 of GARDASIL vaccine (yeast). Additional information has been requested.
In the second week I have light headed, like dizziness and upper back sensitivity to touch as if I was burned from the sun.
4 month-old received Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received DTPa-IPV (Kinrix) (batch number H99J7, expiry date 25th May 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included PEDIARIX.   On 1st November 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 1st November 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 1-Nov-2022 Reporter's comment: The reporter did not consent to follow-up. Additional supportive information: The patient received Kinrix at inappropriate age, which led to inappropriate age at vaccine administration.
I had the Moderna vaccines 1 and 2 with only mild arm soreness. This was my booster, and I got Pfizer. Less than 1/2 hour after the booster, my lips were numb and my face started to have "pins and needles" (not fully numb). By the time it was 1/2 hour after the vaccine, it felt like I had been punched in the jaw on my left side (booster arm side). The numbness and tingling lasted 2 days. The jaw pain lasted 3 days. On day 3 I also got a headache and mild stomach upset. (Arm soreness has been consistent and the redness at the injection site has gotten larger, but that is the only issue at present.) I did not report this to or see any professionals.
Patient received COVID19 vaccination and within 30 seconds experienced nausea and vomiting  2:03 PM Vital Signs: BP 104/62 HR 77 Resp 16 O2Sat 92%  Skin Signs: Warm and dry  Circulation: Cap refill <2sec  Respiratory: Breath sound clear bilaterally  Initial Treatment: Patient monitored, Nausea resolved. Provided water  2:18 PM  Vital Signs: BP 108/71 HR 71 Resp 16 O2Sat 97  Skin Signs: Warm and dry  Circulation: Cap refill <1sec  Respiratory: Breath sound clear bilaterally  BP 120/84 HR 87 Resp 17 O2Sat 99  Skin Signs: Warm and dry  Circulation: Cap refill <1sec  Notes: Patient advised to follow up with medical provider if other symptoms occur. Patient released with parent. Patient and parent instructed to keep well hydrated and to re-introduce food initially as per a BRAT diet.